Shire to buy Baxalta for $32 bln, forging rare diseases leader

LONDON, Jan 11 (Reuters) - Drugmaker Shire Plc clinched its six-month pursuit of Baxalta International Inc on Monday by agreeing a $32 billion cash and stock offer that will make it one of the world's leading rare disease specialists.

from Reuters: New Issues News http://ift.tt/1VZf7FI